Cargando…

572. Adverse Events Following Live Immunization in Patients with DiGeorge Syndrome: A Retrospective, Single Center Study in Korea

BACKGROUND: DiGeorge syndrome (DGS) is a syndrome accompanied by congenital heart defect, hypoparathyroidism and immunodeficiency of varying severity. Live vaccination is generally contraindicated in patients with DGS. However, in real clinical practice, there are cases in which live vaccines are im...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Sung Min, Shin, Je Hee, Baek, Jee Yeon, Lee, Ji Young, Kang, Ji-Man, Ahn, Jong Gyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752896/
http://dx.doi.org/10.1093/ofid/ofac492.625
_version_ 1784850841746800640
author Lim, Sung Min
Shin, Je Hee
Baek, Jee Yeon
Lee, Ji Young
Kang, Ji-Man
Ahn, Jong Gyun
author_facet Lim, Sung Min
Shin, Je Hee
Baek, Jee Yeon
Lee, Ji Young
Kang, Ji-Man
Ahn, Jong Gyun
author_sort Lim, Sung Min
collection PubMed
description BACKGROUND: DiGeorge syndrome (DGS) is a syndrome accompanied by congenital heart defect, hypoparathyroidism and immunodeficiency of varying severity. Live vaccination is generally contraindicated in patients with DGS. However, in real clinical practice, there are cases in which live vaccines are immunized before the diagnosis of DGS or are incidentally immunized. We collected these cases and investigated adverse events (AEs), especially infections caused by the vaccine strains. METHODS: This retrospective study included all patients diagnosed with DGS at Severance Hospital Seoul, Korea, between November 2005 and June 2021. We extracted patients with ICD-10 code (D82.1) and then excluded subjects without genetic confirm. According to the immune status, subjects were categorized into three groups: group A [CD3 < 500 or CD8 < 200 (cells/mm3)], group B [CD3 ≥500 and CD8 ≥ 200 (cells/mm3)] and group C (unknown). RESULTS: Of a total 94 DGS patients, approximately 40% of subjects (38/94) underwent immunological test, of which 21% (8/38) belonged to group A and 79% (30/38) were in group B. Approximately 80% of study subjects (73/94) had a record of at least one live vaccination. By vaccine type, measles-mumps-rubella accounted for the most at 70% (66/94), followed by varicella, bacillus Calmette–Guérin, rotavirus, and live-attenuated Japanese encephalitis virus vaccine. A total of 50 AEs were observed (Figure 1): fever (n=29), URI (n=9), diarrhea (n=4), rash (n=3), thrombocytopenia (n=3), injection site pus (n=1) and febrile convulsion (n=1). Among them 26% (13/50) occurred in group A and no significant difference in the incidence rate of AEs between group A and B was observed (P = 0.14). Six cases of them turned out to be consistent with live vaccination by WHO 2009 causality analysis. Moreover, there were no serious reactions, including ICU hospitalization or death, and there was no emergence of disease caused by vaccine strains. [Figure: see text] CONCLUSION: Our data show that live vaccines were often given without immunologic screening and generally well tolerated in our study population. DISCLOSURES: All Authors: No reported disclosures.
format Online
Article
Text
id pubmed-9752896
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-97528962022-12-16 572. Adverse Events Following Live Immunization in Patients with DiGeorge Syndrome: A Retrospective, Single Center Study in Korea Lim, Sung Min Shin, Je Hee Baek, Jee Yeon Lee, Ji Young Kang, Ji-Man Ahn, Jong Gyun Open Forum Infect Dis Abstracts BACKGROUND: DiGeorge syndrome (DGS) is a syndrome accompanied by congenital heart defect, hypoparathyroidism and immunodeficiency of varying severity. Live vaccination is generally contraindicated in patients with DGS. However, in real clinical practice, there are cases in which live vaccines are immunized before the diagnosis of DGS or are incidentally immunized. We collected these cases and investigated adverse events (AEs), especially infections caused by the vaccine strains. METHODS: This retrospective study included all patients diagnosed with DGS at Severance Hospital Seoul, Korea, between November 2005 and June 2021. We extracted patients with ICD-10 code (D82.1) and then excluded subjects without genetic confirm. According to the immune status, subjects were categorized into three groups: group A [CD3 < 500 or CD8 < 200 (cells/mm3)], group B [CD3 ≥500 and CD8 ≥ 200 (cells/mm3)] and group C (unknown). RESULTS: Of a total 94 DGS patients, approximately 40% of subjects (38/94) underwent immunological test, of which 21% (8/38) belonged to group A and 79% (30/38) were in group B. Approximately 80% of study subjects (73/94) had a record of at least one live vaccination. By vaccine type, measles-mumps-rubella accounted for the most at 70% (66/94), followed by varicella, bacillus Calmette–Guérin, rotavirus, and live-attenuated Japanese encephalitis virus vaccine. A total of 50 AEs were observed (Figure 1): fever (n=29), URI (n=9), diarrhea (n=4), rash (n=3), thrombocytopenia (n=3), injection site pus (n=1) and febrile convulsion (n=1). Among them 26% (13/50) occurred in group A and no significant difference in the incidence rate of AEs between group A and B was observed (P = 0.14). Six cases of them turned out to be consistent with live vaccination by WHO 2009 causality analysis. Moreover, there were no serious reactions, including ICU hospitalization or death, and there was no emergence of disease caused by vaccine strains. [Figure: see text] CONCLUSION: Our data show that live vaccines were often given without immunologic screening and generally well tolerated in our study population. DISCLOSURES: All Authors: No reported disclosures. Oxford University Press 2022-12-15 /pmc/articles/PMC9752896/ http://dx.doi.org/10.1093/ofid/ofac492.625 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstracts
Lim, Sung Min
Shin, Je Hee
Baek, Jee Yeon
Lee, Ji Young
Kang, Ji-Man
Ahn, Jong Gyun
572. Adverse Events Following Live Immunization in Patients with DiGeorge Syndrome: A Retrospective, Single Center Study in Korea
title 572. Adverse Events Following Live Immunization in Patients with DiGeorge Syndrome: A Retrospective, Single Center Study in Korea
title_full 572. Adverse Events Following Live Immunization in Patients with DiGeorge Syndrome: A Retrospective, Single Center Study in Korea
title_fullStr 572. Adverse Events Following Live Immunization in Patients with DiGeorge Syndrome: A Retrospective, Single Center Study in Korea
title_full_unstemmed 572. Adverse Events Following Live Immunization in Patients with DiGeorge Syndrome: A Retrospective, Single Center Study in Korea
title_short 572. Adverse Events Following Live Immunization in Patients with DiGeorge Syndrome: A Retrospective, Single Center Study in Korea
title_sort 572. adverse events following live immunization in patients with digeorge syndrome: a retrospective, single center study in korea
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752896/
http://dx.doi.org/10.1093/ofid/ofac492.625
work_keys_str_mv AT limsungmin 572adverseeventsfollowingliveimmunizationinpatientswithdigeorgesyndromearetrospectivesinglecenterstudyinkorea
AT shinjehee 572adverseeventsfollowingliveimmunizationinpatientswithdigeorgesyndromearetrospectivesinglecenterstudyinkorea
AT baekjeeyeon 572adverseeventsfollowingliveimmunizationinpatientswithdigeorgesyndromearetrospectivesinglecenterstudyinkorea
AT leejiyoung 572adverseeventsfollowingliveimmunizationinpatientswithdigeorgesyndromearetrospectivesinglecenterstudyinkorea
AT kangjiman 572adverseeventsfollowingliveimmunizationinpatientswithdigeorgesyndromearetrospectivesinglecenterstudyinkorea
AT ahnjonggyun 572adverseeventsfollowingliveimmunizationinpatientswithdigeorgesyndromearetrospectivesinglecenterstudyinkorea